Overview
Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects
Status:
Completed
Completed
Trial end date:
2007-10-01
2007-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Criteria
Inclusion Criteria:- Generally healthy subjects men or women aged 18-50
Exclusion Criteria:
- Any significant clinically important disease
- Family history of long QT syndrome and/or sudden cardiac death
- Allergy to moxifloxacin or the quinolone class of antibiotics